We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.55B
AUM Growth
+$122M
Cap. Flow
+$6.03M
Cap. Flow %
0.39%
Top 10 Hldgs %
31.79%
Holding
214
New
9
Increased
74
Reduced
70
Closed
7

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$3.32M
2
MSFT icon
Microsoft
MSFT
+$3M
3
FDX icon
FedEx
FDX
+$1.86M
4
EBAY icon
eBay
EBAY
+$997K
5
SNPS icon
Synopsys
SNPS
+$941K

Sector Composition

Rank Sector Weight
1 Technology 30.41%
2 Healthcare 14.16%
3 Industrials 12.9%
4 Financials 11.51%
5 Consumer Staples 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
26
Unilever
UL
$144B
$23.6M 1.52%
390,359
+3,013
+0.8% +$179K
CACI icon
27
CACI
CACI
$11.3B
$23.4M 1.51%
86,912
+724
+0.8% +$198K
MDT icon
28
Medtronic
MDT
$111B
$22.3M 1.44%
215,921
+2,587
+1% +$300K
PG icon
29
Procter & Gamble
PG
$347B
$20.5M 1.32%
125,387
+2,372
+2% +$352K
PPG icon
30
PPG Industries
PPG
$26.5B
$20.4M 1.31%
118,099
+2,579
+2% +$414K
AAPL icon
31
Apple
AAPL
$4.99T
$19.1M 1.23%
107,784
-240
-0.2% -$37.9K
MTB icon
32
M&T Bank
MTB
$36.6B
$18.9M 1.21%
122,862
+1,903
+2% +$292K
JNJ icon
33
Johnson & Johnson
JNJ
$643B
$18.4M 1.18%
107,641
+1,631
+2% +$267K
FDX icon
34
FedEx
FDX
$74B
$18.2M 1.17%
70,224
-7,731
-10% -$1.86M
WLY icon
35
John Wiley & Sons Class A
WLY
$2.76B
$18M 1.16%
313,868
+4,830
+2% +$261K
GILD icon
36
Gilead Sciences
GILD
$167B
$17.7M 1.14%
243,296
+7,042
+3% +$485K
REGN icon
37
Regeneron Pharmaceuticals
REGN
$72.9B
$17.6M 1.13%
27,797
+1,766
+7% +$1.09M
BC icon
38
Brunswick
BC
$5.33B
$17M 1.09%
168,603
-33,883
-17% -$3.32M
SNY icon
39
Sanofi
SNY
$109B
$16.8M 1.08%
334,990
+6,976
+2% +$345K
ZBH icon
40
Zimmer Biomet
ZBH
$18.5B
$16.2M 1.04%
131,448
+57
+0% +$7.46K
CTSH icon
41
Cognizant
CTSH
$23.8B
$16M 1.03%
180,478
+5,757
+3% +$463K
CVX icon
42
Chevron
CVX
$374B
$15.7M 1.01%
133,584
+1,050
+0.8% +$119K
HXL icon
43
Hexcel
HXL
$8.3B
$14.9M 0.96%
287,637
+11,415
+4% +$646K
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$14.7M 0.95%
22,027
-249
-1% -$155K
DVN icon
45
Devon Energy
DVN
$49.2B
$14.6M 0.94%
331,229
-5,380
-2% -$224K
GLW icon
46
Corning
GLW
$108B
$13.4M 0.87%
361,369
+12,886
+4% +$483K
NVS icon
47
Novartis
NVS
$304B
$11.3M 0.73%
129,585
+3,940
+3% +$327K
BLKB icon
48
Blackbaud
BLKB
$1.65B
$10.4M 0.67%
131,415
+6,695
+5% +$517K
XOM icon
49
ExxonMobil
XOM
$634B
$9.74M 0.63%
159,210
-985
-0.6% -$61.6K
RDS.B
50
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$9.51M 0.61%
219,391
+768
+0.4% +$34.6K

Similar funds

Grandfield & Dodd's Q4 2021 Portfolio in Review

As of Q4 2021, Grandfield & Dodd held 214 positions worth $1.55B, up 8.5% from $1.43B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q4 2021 filing shows 9 new, 74 increased, 70 reduced and 7 closed positions. Its largest new stake was People Inc: 14,217 shares worth $1.52M. The largest sale was Brunswick, an estimated $3.32M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q4 2021 buy was People Inc: 14,217 shares worth $1.52M.
  • Grandfield & Dodd added most to AutoZone in Q4 2021, an estimated $2.5M increase.
  • Grandfield & Dodd's biggest Q4 2021 reduction was Brunswick, cutting an estimated $3.32M.
  • Grandfield & Dodd fully exited Emcor in Q4 2021, selling an estimated $270K.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.55B portfolio in Q4 2021.
  • Grandfield & Dodd opened 9 new positions and closed 7 in Q4 2021.
  • Grandfield & Dodd's portfolio value rose 8.5% quarter-over-quarter to $1.55B.

Based on Grandfield & Dodd's 13F filing for Q4 2021, filed 8 Feb 2022.